Conditional marketing authorisation of therapeutic medicines for solid tumours in the European Union: methodological and clinical challenges.

IF 2.5 3区医学 Q3 PHARMACOLOGY & PHARMACY

Expert Opinion on Pharmacotherapy Pub Date : 2025-05-11 DOI:10.1080/14656566.2025.2504699

Stefania Bellino, Anna La Salvia

引用次数: 0

查看原文本刊更多论文

欧盟实体肿瘤治疗药物的有条件上市许可：方法学和临床挑战

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Expert Opinion on Pharmacotherapy 医学-药学

CiteScore

5.60

自引率

3.10%

发文量

163

审稿时长

4-8 weeks

期刊介绍： Expert Opinion on Pharmacotherapy is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on newly approved/near to launch compounds mainly of chemical/synthetic origin, providing expert opinion on the likely impact of these new agents on existing pharmacotherapy of specific diseases.